Weinberg, Jessica R.
Voudouri, Mariana
Keil, Meg
Stratakis, Constantine A.
Tatsi, Christina http://orcid.org/0000-0002-2882-4584
Article History
Received: 16 May 2023
Revised: 2 November 2023
Accepted: 5 November 2023
First Online: 22 November 2023
Competing interests
: Dr. Stratakis holds patents on the function of the PRKAR1A, PED11A, and GPR101 genes and related issues; his laboratory has also received research funding on the GPR101 gene, and on abnormal growth hormone secretion and its treatment by Pfizer, Inc. He is currently employed by ELPEN, SA and has been consulting for Lundbeck Pharmaceuticals and Sync, SA. Dr. Tatsi received funding by Pfizer, Inc., for unrelated studies.
: All study procedures were approved by the <i>Eunice Kennedy Shriver</i> National Institute of Child Health & Human Development (NICHD) Institutional Review Board. Consent was obtained from participants and/or their parent or legal guardian to participate in the study.